ArticleRSC advances2025
Development and application of coffee husk-based polyaniline composite (CF@PANi) for enhanced ammonium removal from aqueous solutions.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study focuses on the development and evaluation of a novel composite material, designated as CF@PANi, which integrates coffee husk and polyaniline for the purpose of ammonium adsorption from aqueous solutions. The composite was synthesized under optimized conditions and characterized using various analytical techniques. The results from SEM and EDS indicated significant structural and compositional changes following the adsorption process, including an increase in porosity and a notable rise in nitrogen content from 6.35% to 17.24%, thereby confirming effective ammonium uptake. BET analysis revealed that the synthesized composite possesses a mesoporous structure with a surface area of 7.0642 m
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.